In MCs, the median levels of N-cadherin, CK18, and CK19 expression were 0.264, 0.079, and 3.214 in breast cancer patients and 0.195, 0.062, and 2.228 in HVs, respectively. The gene discussed is KRT19; the disease is breast carcinoma.